Literature DB >> 11923300

Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1/2 pathways.

John F Kuemmerle1, Huiping Zhou.   

Abstract

Insulin-like growth factor-binding protein-5 (IGFBP-5) and insulin-like growth factor-I (IGF-I) are produced by human intestinal smooth muscle cells. Endogenous IGF-I stimulates growth and increases IGFBP-5 secretion. IGFBP-5 augments the effects of IGF-I by facilitating interaction of IGF-I with the IGF-I receptor tyrosine kinase. Andress (Andress, D. L. (1998) Am. J. Physiol. 274, E744-E750) and Berfield et al. (Berfield, A. K., Andress, D. L., and Abrass, C. K. (2000) Kidney Int. 57, 1991-2003) have shown that in osteoblasts and kidney mesangial cells, IGFBP-5 stimulates proliferation and filopodia formation independently of IGF-I, presumably by activating a distinct IGFBP-5 receptor serine kinase. The present study determined whether IGFBP-5 exerts direct effects on growth in human intestinal smooth muscle cells and identified the intracellular signaling pathways involved. IGFBP-5 caused a concentration-dependent increase in [(3)H]thymidine incorporation and an increase in IGF-I secretion that occurred independently of IGF-I and the IGF-I receptor tyrosine kinase. IGFBP-5-induced phosphorylation of p38 MAP kinase, which was abolished by SB203580, or expression of a dominant negative Ras mutant, Ras(S17N), and phosphorylation of Erk1/2, which was abolished by a Raf1 kinase inhibitor, U1026, or expression of Ras(S17N). IGFBP-5-stimulated [(3)H]thymidine incorporation and IGF-I secretion were partly inhibited by SB203580 or U1026 and abolished by the combination of the two inhibitors or by expression of Ras(S17N). These data show that IGFBP-5 stimulates growth and IGF-I secretion in human intestinal smooth muscle cells by activation of p38 MAP kinase-dependent and Erk1/2-dependent pathways that are independent of IGF-I. A positive feedback mechanism therefore links IGFBP-5 and IGF-I secretion that reinforces their individual effects on growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923300     DOI: 10.1074/jbc.M200885200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Decreased expression of insulin-like growth factor binding protein-5 during N-(4-hydroxyphenyl)retinamide-induced neuronal differentiation of ARPE-19 human retinal pigment epithelial cells: regulation by CCAAT/enhancer-binding protein.

Authors:  William Samuel; R Krishnan Kutty; Camasamudram Vijayasarathy; Iranzu Pascual; Todd Duncan; T Michael Redmond
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

2.  Amelioration of excess collagen IαI, fibrosis, and smooth muscle growth in TNBS-induced colitis in IGF-I(+/-) mice.

Authors:  Sunila Mahavadi; Robert S Flynn; John R Grider; Li-Ya Qiao; Karnam S Murthy; Krystina B Hazelgrove; John F Kuemmerle
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

3.  Distinct gene expression profile of human mesenchymal stem cells in comparison to skin fibroblasts employing cDNA microarray analysis of 9600 genes.

Authors:  Cornelia Brendel; Larissa Kuklick; Oliver Hartmann; Theo Daniel Kim; Ulrich Boudriot; Dagmar Schwell; Andreas Neubauer
Journal:  Gene Expr       Date:  2005

4.  Endogenous IGF-I and alphaVbeta3 integrin ligands regulate increased smooth muscle hyperplasia in stricturing Crohn's disease.

Authors:  Robert S Flynn; Karnam S Murthy; John R Grider; John M Kellum; John F Kuemmerle
Journal:  Gastroenterology       Date:  2009-09-12       Impact factor: 22.682

5.  Blunted satellite cell response is associated with dysregulated IGF-1 expression after exercise with age.

Authors:  Daniel R Moore; Bryon R McKay; Mark A Tarnopolsky; Gianni Parise
Journal:  Eur J Appl Physiol       Date:  2018-07-31       Impact factor: 3.078

6.  IGFBP5 enhances osteogenic differentiation potential of periodontal ligament stem cells and Wharton's jelly umbilical cord stem cells, via the JNK and MEK/Erk signalling pathways.

Authors:  Yuejun Wang; Zhi Jia; Shu Diao; Xiao Lin; Xiaomeng Lian; Liping Wang; Rui Dong; Dayong Liu; Zhipeng Fan
Journal:  Cell Prolif       Date:  2016-08-03       Impact factor: 6.831

7.  Ras-association domain family 1 protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation.

Authors:  Yousef G Amaar; David J Baylink; Subburaman Mohan
Journal:  J Bone Miner Res       Date:  2005-03-14       Impact factor: 6.741

Review 8.  Intestinal adaptation after massive intestinal resection.

Authors:  A R Weale; A G Edwards; M Bailey; P A Lear
Journal:  Postgrad Med J       Date:  2005-03       Impact factor: 2.401

9.  The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanisms.

Authors:  Hidekata Yasuoka; Eileen Hsu; Ximena D Ruiz; Richard A Steinman; Augustine M K Choi; Carol A Feghali-Bostwick
Journal:  Am J Pathol       Date:  2009-07-23       Impact factor: 4.307

10.  The subcellular localization of IGFBP5 affects its cell growth and migration functions in breast cancer.

Authors:  Mustafa Akkiprik; Limei Hu; Aysegul Sahin; Xishan Hao; Wei Zhang
Journal:  BMC Cancer       Date:  2009-04-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.